STOCK TITAN

Capital Research (TDG) discloses 3,146,345-share holding, 5.6% stake

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

TransDigm Group Inc. reports a Schedule 13G disclosure showing Capital Research Global Investors beneficially owns 3,146,345 shares of common stock as of 03/31/2026. The filing states this equals 5.6% of 56,473,563 shares believed to be outstanding, with sole voting power of 3,138,786 and sole dispositive power of 3,146,345. The filing is signed by a Capital Research official on 05/11/2026.

Positive

  • None.

Negative

  • None.

Insights

Institutional stake disclosed: CRGI holds 3,146,345 shares (5.6%).

Capital Research Global Investors is shown as the beneficial owner of 3,146,345 shares with sole voting power of 3,138,786, per the Schedule 13G filed for the period ending 03/31/2026. The filing attributes ownership across named investment management entities under CRGI.

This is a passive ownership disclosure typical for large asset managers; any trading activity or intent is not stated here. Subsequent filings would show changes in position.

Filing documents voting and dispositive powers held by CRGI over TDG shares.

The Schedule 13G lists specific voting and dispositive counts: sole voting power 3,138,786 and sole dispositive power 3,146,345. It also cites a total outstanding share figure of 56,473,563 used to calculate the 5.6% stake.

As a passive investor disclosure, this does not indicate control or activist intent; governance implications depend on future changes or disclosures.

Reporting period 03/31/2026 Schedule 13G reporting date
Beneficially owned shares 3,146,345 shares Amount beneficially owned by Capital Research Global Investors
Percent of class 5.6% Percent of 56,473,563 shares believed to be outstanding
Shares outstanding (basis) 56,473,563 shares Shares believed to be outstanding used for percent calculation
Sole voting power 3,138,786 shares Sole power to vote or direct the vote
CUSIP 893641100 TransDigm common stock identifier
Schedule 13G regulatory
"Capital Research Global Investors is deemed to be the beneficial owner"
A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.
beneficially owned financial
"Amount beneficially owned: 3,146,345"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
sole dispositive power regulatory
"Sole power to dispose or to direct the disposition of: 3,146,345"
Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.





893641100

(CUSIP Number)
03/31/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G



Capital Research Global Investors
Signature:Jae Won Chung
Name/Title:Vice President and Senior Counsel II, Capital Research and Management Company
Date:05/11/2026

FAQ

What stake does Capital Research Global Investors report in TDG?

Capital Research Global Investors reports beneficial ownership of 3,146,345 shares of TransDigm common stock, representing 5.6% of 56,473,563 shares believed outstanding as of 03/31/2026.

What voting power does CRGI hold according to the Schedule 13G?

The filing shows CRGI has sole voting power for 3,138,786 shares and sole dispositive power for 3,146,345 shares, per the Schedule 13G signed on 05/11/2026.

Does the Schedule 13G indicate CRGI plans to exert control over TDG?

No explicit control intent is stated. The Schedule 13G lists passive beneficial ownership and voting/dispositive counts but does not state any plan to seek control or activism.

What date and CUSIP are associated with this filing for TDG?

The filing references the reporting date 03/31/2026 and identifies TransDigm common stock CUSIP 893641100; it was signed on 05/11/2026 by a Capital Research official.